Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion

American Journal of Cardiology

Volumn 78, Issue 10, 1996, Pages 1161-1163

  Kereiakes, Dean J ^a,b   Essell, James H ^a   Abbottsmith, Charles W ^a   Broderick, Thomas M ^a   Runyon, John Paul ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b The Carl & Edyth Lindner Center for Research & Education   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTITHROMBOCYTIC AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PLATELET TRANSFUSION; THROMBOCYTOPENIA;

EID: 0030588456     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)90072-7     Document Type: Article

References (8)

1. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
2. Lincoff AM, Tcheng JE, Bass TA, Popma JJ, Teirstein PS, Kleiman NS, Weisman HF, Musco MH, Cabot CE, Berdan LG, Califf RM, Topol EJ. A multicenter, randomized, double-blind pilot trial of standard versus low dose weight-adjusted heparin in patients treated with the platelet GP IIb/IIIa receptor antibody c7E3 during percutaneous coronary revascularization (abstr). J Am Coll Cardiol 1995;25:80A.
3. Berkowitz SD, Sane DC, Shavender JH, Sigmon KN, Topol EJ, Califf RM. Analysis of the occurrence and clinical significance of thrombocytopenia with c7E3 (abciximab) in the EPIC trial (abstr). J Am Coll Cardiol 1996;27:82A.
4. Imbach P. New clinical aspects of immune thrombocytopenic purpura (ITP). In: Immunotherapy with Intravenous Immunoglobulins. London: Academic Press, 1991:239-243.
5. Berchtold P, McMillan R. Intravenous immunoglobin: new aspects of mechanism of action in chronic ITP. In: Imbach P. ed. Immunotherapy with Intravenous Immunoglobulins. London: Academic Press, 1991:245-252.
6. Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med 1992; 326:107-116.
7. Mak KH, Kottke-Marchant K, Brooks LM, Apheart KL, Topol EJ. Potential value of platelet GPIIb/IIIa antagonist for treating heparin-induced thrombocytopenia (HIT) (abstr). J Am Coll Cardiol 1996;27:316A.
8. Bauman MA, Mentore JE, Aster RH, Anderson T. Urgent treatment of idiopathic thrombocytopenic purpura with single dose gamma-globulin infusion followed by platelet transfusion. Ann Int Med 1986;104:808-817.